DE:7C8 Stock Latest News
Company AnnouncementsInvion secures major funding as Photosoft cancer trial advances to Phase II5d ago
Company AnnouncementsInvion Moves to Fully Virtual AGM and Paperless Meeting Materials1w ago
Company AnnouncementsInvion Plans New Share and Option Issue in ASX Placement1w ago
Company AnnouncementsInvion secures financing to cover up to 85% of clinical trial costs1w ago
Company AnnouncementsInvion and Percheron Align on Novel Cancer Combination Using Photosoft and VISTA Immunotherapy2w ago
Company AnnouncementsPercheron and Invion pair VISTA immunotherapy with Photosoft cancer PDT2w agoCompany AnnouncementsInvion Advances Photosoft-Based Skin Cancer Therapy After Strong Phase I Safety Readouts2w ago
- Company AnnouncementsInvion Secures $400,000 in Director Loans to Support Working Capital1M ago
- Company AnnouncementsInvion Sets Out 2026 Governance Framework and Board Changes2M ago
Company AnnouncementsInvion Narrows Annual Loss but Net Tangible Assets Slide Deeper Into Negative Territory2M ago
Company AnnouncementsInvion Appoints New Director With No Current Securities Interests2M ago
Company AnnouncementsInvion strengthens clinical leadership and expands Photosoft into new cancer and eye indications3M agoCompany AnnouncementsInvion Issues New Tranches of Unquoted Options to Strengthen Capital Structure4M ago
Company AnnouncementsInvion boosts PDT push with appointment of global clinical leader Colin Hopper4M ago
Company AnnouncementsInvion boosts director equity stake with new incentive options4M ago
Company AnnouncementsInvion Issues 671,882 Unquoted Convertible Notes as Part of Funding Strategy4M ago
Company AnnouncementsInvion secures strong shareholder backing for capital measures at EGM5M ago
Company AnnouncementsInvion corrects director shareholding disclosure in ASX filing5M agoCompany AnnouncementsInvion bolsters funding as Photosoft cancer programs show promising progress6M ago